Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.91 USD | +2.25% | -1.92% | -33.91% |
05-07 | MoonLake Immunotherapeutics Q1 Net Loss Widens | MT |
05-07 | MoonLake Immunotherapeutics Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.91% | 2.51B | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-0.99% | 21.97B | |
-5.15% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- MLTX Stock
- News MoonLake Immunotherapeutics
- Moonlake Immunotherapeutics Insider Sold Shares Worth $6,803,044, According to a Recent SEC Filing